Optra system a leading life science and healthcare IT consulting company announced its joining the Microsoft BioIT alliances.
“We are delighted to welcome Optra system in to the BioIT alliances,” said Dr. Rudy Potenzone, Director of the alliance and Worldwide Pharmaceutical industry technology Strategies. “Optra system expertise in Life science and Healthcare Image Informatics space and a range of solutions for preclinical and clinical imaging adds a new perspective to the BioIT Alliance.
Abhi Gopalap, President and CEO of Optra System said “We are pleased to be a member of the Microsoft BioIT Alliance, we look forward to work closely with Microsoft and the other Alliance members. OPTRA with its array of solutions and offerings would enable the alliance members make more effective use of technology for research and development and advancing new products.” Optra systems has been a key partner for many life science and healthcare companies for developing complete workflow management including Image acquisition, storage, processing, analyzing and reporting. OPTRA has a vast experience and is supporting renowned academic institutions to speed up their research in Bioinformatics, Systems Biology, and Translational Medicine. Many pharmaceutical and Biotech companies rely on Optra for their needs like system integration, enterprise and business intelligence, data integration management, etc. Optra system is also partnering with microscopy and instrumentation companies to develop new products and solutions.
The Alliance brings together pharmaceutical, biotechnology, hardware, and software industries to explore new ways to share complex biomedical data and collaborate among multi-disciplinary teams to expedite discovery in the life sciences. It also enables the members to identify new technologies to over come the challenges faced by life science companies like data integration, collaboration, and knowledge management that cannot be solved by any organization alone.
Source: Life sciences Industry News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment